Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
149,200,472
-
Share change
-
-3,563,805
-
Total reported value
-
$1,879,908,994
-
Put/Call ratio
-
45%
-
Price per share
-
$12.60
-
Number of holders
-
218
-
Value change
-
-$39,491,355
-
Number of buys
-
104
-
Number of sells
-
81
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q3 2022
As of 30 Sep 2022,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
149,200,472 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, STATE STREET CORP, Avoro Capital Advisors LLC, FMR LLC, Fisher Asset Management, LLC, PICTET ASSET MANAGEMENT SA, RP Management, LLC, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
218
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.